NOJA ONUOHA: Open Payments
NPI 1386965986 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$326 in 14 payments from 9 companies in 2025. Trend: 2023 $934 · 2024 $1,082 · 2025 $326
Food & beverage: $326
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 2 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Alkermes, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Indivior Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $19 |
Products named: VRAYLAR, REXULTI, COBENFY, ARISTADA, CAPLYTA, AUSTEDO XR, INGREZZA, SUBLOCADE.
Industry payments across CA — which companies pay providers there.
